Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Sep 3, 2007 |
Overview of Child Welfare Services in Tennessee StateTennessee's child welfare system has undergone dramatic changes over the past few years. Throughout the 1980s and early 1990s, child welfare in Tennessee was under-funded and fragmented among six state agencies that failed to communicate with one another or coordinate their efforts. In 1996, a single state agency, the Department of Children's Services (DCS) was created by executive order to house child welfare and juvenile justice services. In 2000, Children's Rights, a national non-profit that advocates for children in foster care, filed a class action lawsuit, claiming over-utilization of emergency shelters and large group facilities, untrained caseworkers, high levels of placement instability, inadequate efforts to achieve permanency, inadequate educational services and disparate treatment of African-American children in foster care. More info |
Health Topics |
| Jul 2, 2007 |
Overview of Child Welfare Services in Washington StateCompared to other states, child welfare is high on the list of legislative priorities in Washington. This high level of legislative activity can be attributed in part to a number of recent events that are briefly described below. In addition, the legislature, particularly the House, has a number of experienced champions of children's issues, including Rep. Ruth Kagi, chair of the House Early Learning and Children's Services Committee, and Rep. Mary Lou Dickerson, chair of the House Human Services Committee, among others. More info |
Health Topics |
| Jan 2, 2012 |
Patient Story: Jamel Sawyer: A Young Man Fights MRSAOne of the most notorious multidrug-resistant superbugs, MRSA is responsible for an estimated 19,000 deaths and 360,000 hospitalizations each year in this country. Jamel’s story illustrates the twin dangers presented by emerging multidrug-resistant bacterial infections and the waning effectiveness and availability of drugs to treat them. More info |
Antibiotic Innovation |
| Jul 20, 2012 |
Pew Asks FDA to Close Loopholes in New Guidelines to Protect Antibiotics From OverusePew's Laura Rogers, program director of the Human Health and Industrial Farming initiative, commended the U.S. Food and Drug Administration (FDA) for issuing Draft Guidance 213 for industry on antibiotics in animal feed and water and urged the agency to consider improvements that would better protect public health. More info |
Antibiotics in Food Animal Production |
| Jul 20, 2012 |
Pew Asks FDA to Strengthen Guidelines on Antibiotic Use in Food AnimalsPew's Human Health and Industrial Farming team has applauded the U.S. Food and Drug Administration (FDA) for issuing Guide 209. However, they would like to see additional strengthening measures, which can help begin the process of making progress toward reducing the development and spread of antibiotic-resistant bacterial infections in people. More info |
Antibiotics in Food Animal Production |
| Aug 23, 2012 |
Pew Biomedical Scholar Profile: Sohini RamachandranSohini Ramachandran, a population geneticist at Brown University in Providence, Rhode Island, received two high-profile awards this year. In June, she was named a Pew Scholar in Biomedical Sciences by the Pew Charitable Trusts, based in Philadelphia, Pennsylvania; and in February, she received a fellowship from the Alfred P. Sloan Foundation in New York. She plans to use the grants to distinguish herself in a fast-moving field. More info |
Biomedical Research |
| Nov 21, 2012 |
Pew Comments on Advance Notice of Proposed Rulemaking ''Antimicrobial Animal Drug Sales and Distribution Reporting''The Pew Campaign on Human Health and Industrial Farming submitted a letter to the U.S. Food and Drug Administration, urging the FDA to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
Antibiotics in Food Animal Production |
| Apr 9, 2013 |
Pew Comments on Centers for Medicaid and Medicare Services' Information Collection Activities Draft GuidanceThe Pew Charitable Trusts appreciates this opportunity to submit comments to CMS's "Information Collection Activities" draft guidance. We suggest that both the research and non-research payment templates be modified in order to make it easier for consumers to identify which drugs, devices, biologicals, or medical supplies are associated with particular transfers of value. More info |
|
| Aug 3, 2012 |
Pew Comments on Draft Guidance for Industry Regarding Nanotechnology in FoodThe Food Additives Project of the Pew Health Group strongly agrees with the FDA's draft decision to deny "generally recognized as safe" (GRAS) status to nanoengineered chemicals and review them as food additives. However, they list their concerns with certain aspects of the document and question the agency's claim that it has not reviewed GRAS notifications sanctioning the use of nanoengineered chemicals. More info |
Food Additives |
| Apr 4, 2013 |
Pew Comments on Draft Recommendations for Meaningful Use, Stage 3The Pew Charitable Trusts submitted comments on preliminary recommendations regarding Stage 3 meaningful use objectives and standards for electronic health records (EHRs) to the Office of the National Coordinator for Health Information Technology. These comments follow remarks at recent meetings of the Health Information Technology (HIT) Policy Committee and HIT Standards Committee. More info |
|
| Nov 8, 2012 |
Pew Comments to the FDA Regarding the Unique Device Identification SystemPew’s Medical Device Initiative, along with the American Heart Association and Trust for America’s Health, submitted comments to the U.S. Food and Drug Administration (FDA) regarding its proposed rule for a unique device identification (UDI) system for medical devices. Once implemented by the FDA and utilized by healthcare providers, the UDI system will be the cornerstone for significant improvements in postmarketing surveillance of medical devices. More info |
Drugs and Devices at the FDA |
| Feb 17, 2012 |
Pew Health Group comments on the implementation of Section 6002 of the Patient Protection and Affordable Care Act"The Pew Health Group of The Pew Charitable Trusts welcomes the opportunity to submit comments regarding the Centers for Medicare & Medicaid Services' ("CMS") proposed rule for Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Interests." More info |
Conflicts of Interest |
| Jul 21, 2009 |
Pew letter to the FDA in response to their public recognition of animal agriculture's contribution to antimicrobial resistanceThe Pew Campaign on Human Health and Industrial Farming (Pew) would like to extend our sincere thanks to you both for taking the time to meet with us on June 23 to discuss the contribution of animal agriculture to the growing public health crisis of antimicrobial resistance. We are deeply appreciative not only of your consideration of our viewpoints, but also the expertise and dedication that you bring to the U.S. Food and Drug Administration (FDA). More info |
Antibiotics in Food Animal Production |
| Jul 20, 2012 |
Pew Seeks More Veterinary Oversight of Antibiotic Use on Industrial FarmsGail Hansen, a senior officer with the Pew Health Group, thanks the U.S. Food and Drug Administration (FDA) for issuing draft codified language expanding the Veterinary Feed Directive (VFD). She also raises several concerns with the language that should be addressed. More info |
Antibiotics in Food Animal Production |
| Mar 10, 2010 |
Pew Statement on Energy and Commerce Drug Safety Hearing"Two years after dozens of Americans lost their lives to contaminated heparin, we are still unable to protect U.S. consumers from many of the risks of pharmaceuticals manufactured in foreign factories. It is time for Congress to take action to better protect health." More info |
Drug Manufacturing and Distribution, Drug Safety |
| May 9, 2013 |
Pew Testimony on the Safety of Compounding PharmaciesThe U.S. Senate Committee on Health, Education, Labor and Pensions held a hearing on May 9 entitled "Pharmaceutical Compounding: Proposed Legislative Solution." Pew's Allan Coukell, a pharmacist and drug safety expert, testified on the need to strengthen oversight of the compounding industry. More info |
|
| Apr 25, 2013 |
Pew Testimony to House Energy and Commerce Subcommittee on Health Regarding Drug Supply ChainThe House Energy & Commerce Subcommittee on Health will hold a hearing on April 25 entitled "Securing Our Nation’s Prescription Drug Supply Chain." Allan Coukell, a pharmacist and drug safety expert, will testify on the need to establish a national system to track and authenticate medicine. The principles outlined in his prepared testimony are supported by other stakeholders in statements from consumer, patient, public health, and industry groups. More info |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 22, 2012 |
Pew's Comment Letter on FDA’s Advanced Notice of Proposed Rulemaking Regarding Data CollectionOn behalf of The Pew Charitable Trusts (Pew), we are writing to urge the U.S. Food and Drug Administration (FDA) to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
|
| Jan 28, 2009 |
Pharmaceutical Industry MarketingReports of pharmaceutical and medical device industry marketing expenditures vary - pharmaceutical manufacturers spend billions annually on marketing - detailing, journal advertising, pharmaceutical samples and direct-to-consumer advertising. What can be done to protect patients, control health care costs, and bolster professionalism among physicians? The Prescription Project promotes a range of solutions for consumers, physicians, state and federal policy makers, and public and private payers. More info |
Conflicts of Interest |
| Mar 23, 2010 |
Physician Payments Sunshine Provisions in Health Care ReformThe Physician Payments Sunshine provisions in health care reform legislation require drug and medical device manufacturers to publicly report gifts and payments made to physicians and teaching hospitals. More info |
Conflicts of Interest |
| Feb 19, 2010 |
Produce Safety Project: Stakeholders' Discussion Series MeetingsThe Food and Drug Administration announced in December 2009, that it was going to establish a nationwide produce safety standard for the growing, harvesting and packing of fresh fruits and vegetables and opened an official docket for comments in February 2010. More info |
Food Safety |
| Nov 19, 2008 |
Produce-Related Foodborne-Illness OutbreaksFrom 1990 through 2005, at least 713 produce-related outbreaks have occurred. This issue brief summarizes 15 years of produce-related illness outbreaks in the U.S. More info |
Food Safety |
| Jan 6, 2012 |
Project on Emerging NanotechnologiesMomentous change can come in tiny packages. Nanotechnologies have been hailed by many as the next industrial revolution, likely to affect everything from clothing and medical treatments to engineering. Although focused on the very small, nanotechnology—the ability to measure, manipulate and manufacture objects that are 1/100th to 1/100,000th the circumference of a human hair—offers immense promise. Whether used in cancer therapies, pollution-eating compounds or stain-resistant apparel, these atomic marvels are radically and rapidly changing the way we live. The National Science Foundation predicts that the global marketplace for goods and services using nanotechnologies will grow to $1 trillion by 2015 and employ 2 million workers. More info |
Health Topics |
| Nov 19, 2012 |
Public Health and Consumer Groups Call for Participation in Antibiotic Use MeetingsOn Nov. 2, 15 public health and consumer organizations sent a joint letter to the FDA requesting to join in discussions to consider how the misuse and overuse of antibiotics in livestock and poultry are significant contributing factors to antibiotic resistance in humans. More info |
Antibiotics in Food Animal Production |
| Feb 22, 2012 |
Recommendations to the FDA Regarding the Use of Antibiotics in Food Animal ProductionIt is estimated that up to 70 percent of antibiotics sold in the U.S. are used on industrial farms in healthy food animals, to promote growth and to compensate for the effects of overcrowded and unsanitary conditions. This practice promotes the development of deadly strains of antibiotic-resistant bacteria that can spread to humans. More info |
